NCT07597005Recruiting
Red Propolis Supplementation as a Strategy in Chronic Kidney Disease
Red Propolis as a Strategy to Modulate Inflammation and Oxidative Stress in Patients With Chronic Kidney Disease
Source: ClinicalTrials.gov · Last updated 19 May 2026
Brief summary (registry, in English)
The objective of this study is to evaluate the effects of red propolis on inflammation and oxidative stress in patients with chronic kidney disease on conservative management.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- First submitted
- 12 May 2026
- Start date
- 30 Sept 2025
- Primary completion date
- 30 Nov 2025
- Lead sponsor
- Universidade Federal Fluminense
- Diseases
- Chronic kidney disease
- NCT number
- NCT07597005
What you commit to
- Study type: Interventional
- Planned participants: 40
- From 30 Sept 2025 to the primary completion date, 30 Nov 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- patients with autoimmune and infectious diseases,
- patients with cancer, liver disease, and AIDS
Other
- pregnant,
- lactating,
- smoker
- patients using antibiotics and antioxidant supplements in the last three months
Who the study is looking for
- patients with CKD stages 3-5 under conservative management
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Denise mafra Coordinator of this site? Confirm its status | Rio de Janeiro | Brazil | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.